INTRODUCTION
Juvenile idiopathic arthritis (juvenile rheumatoid arthritis, JIA) is the most prevalent paediatric rheumatic diagnosis among children in many countries (Glass and Giannini, 1999) . JIA is a clinically heterogeneous group of phenotypes that have in common chronic inflammatory synovitis in children under the age of 16 (Prahalad et al., 2001) . Seven subtypes of JIA, based on the clinical characteristics at onset are distinguished; including the more frequent oligo, poly, psoriatic and systemic JIA variants (Petty at al., 2004) . The genetic contributions to disease risk have been observed in many case/control studies (Glass and Giannini, 1999; Prahalad et al., 2001) . A genome scan revealed linkage of JIA to the HLA region, additional evidence supporting linkage of JIA was observed at 1p36, 19p13, and 20q13 (Thompson et al., 2004) . However, the low odds ratios for most individual "JIA risk alleles" suggest that gene-gene interactions, which are poorly described or understood at present, likely influence whether pathology develops (Glass and Giannini, 1999) . This consideration encourages extension of the search for JIA candidate genes.
The chromosome 14q region appears to be prospective for the above goal, as it harbours several genes of interest. Linkage of the locus to autoimmune diseases has been already reported (John and Worthington, 2001 ). Possible candidate genes include the genes encoding the nuclear factor kappa B inhibitor (NFKBI) on 14q13 (le Beau et al., 1992) , the transcription factor FOS on 14q23, TGF-beta3 on 14q24, and immunoglobulin heavy chain locus at 14q32.33 (Kamnasaran and Cox, 2002) . Several proteasomal genes are located at 14q including proteasomal activator subunits 1 and 2 (PSME1 and PSME2, respectively) and proteasome PROCEEDINGS OF THE LATVIAN ACADEMY OF SCIENCES. Section B, Vol. 63 (2009), No. 4/5 (663/664) subunit of beta type 5 (PSMB5) at 14q11.2, proteasome subunits of alpha type 6 (PSMA6) at 14q13, and alpha type 3 (PSMA3) at 14q23 (Chistyakov et al., 2000) .
The proteasome is a multisubunit enzyme complex which plays a central role in the degradation of proteins controlling transcription rate, cell-cycle progression and apoptosis; therefore, an important role in pathogenesis of human diseases has been ascribed to the structure (Glickman et al., 2001; Almond et al., 2002; Naujokat et al., 2002; Sjakste et al., 2002a; 2002b) . To a known extent, proteasomes interfere also with the atherogenesis process. Proteasomes degrade IF-kB factor with subsequent activation of the atherogenic NF-kB (Wilson et al., 2001) . Oxydised LDL causes activation of the proteasome activity followed by decline of this activity. HDL is an inhibitor of the proteasome activity (Vieira et al., 2000; Robbesyn et al., 2003) .
The latter gene group appears to be of special interest as it was shown that the proteasomal protein LMP2 gene polymorphism affects the susceptibility to, and severity of HLA-B27 associated juvenile idiopathic arthritis (Pryhuber et al., 1996) . We have previously addressed the possible association of the PSMA6 gene in the genetic susceptibility to various diseases. The PSMA6 gene is encoded by a single-copy gene on chromosome 14q13.2 between markers D14S960 and D14S889 (Sjakste et al., 2001) . In the initial studies we investigated a microsatellite polymorphism in intron 6 of the gene in several human populations (Sjakste et al., 2002c) . Further studies showed that this marker is associated with Graves' disease (Sjakste et al., 2004) and diabetes mellitus type 2 (DM2, Kalis et al., 2002; Sjakste et al., 2007a) . Genotyping of the single nucleotide polymorphism (SNP) in the promoter and 5'-UTR region of the PSMA6 gene, resulted in the discovery of the association of the genotype -8C/G and haplotype C -110 /G -8 with a higher risk of DM2 (Sjakste et al., 2007b) .
In this study we investigated whether chromosome 14q region SNP is associated with increased risk of juvenile idiopathic arthritis.
MATERIALS AND METHODS
Case/control study description. The polymorphisms were genotyped in a case/control study of 156 juvenile idiopathic arthritis patients and 214 subjects without JIA from the Latvian population. The case group (63% females) consisted of patients attending the outpatient clinic at the Pauls Stradiòð Clinical University Hospital and the Children's Hospital "Gaiïezers". The group represented about 60% of all registered in Latvia JIA patients. Patients (57% females) to the Rîga Biíernieki Hospital specialised in trauma medicine, were recruited to participate in the study control group (without autoimmune diseases). Informed consent was obtained from all patients; the study was approved by the Central Medical Ethics Commission of the Latvian Medical Academy.
DNA extraction was performed using a kit for genomic DNA extraction from nucleated blood cells (Fermentas, Vilnius, Lithuania) . DNA quantity and quality was determined by electrophoresis in agarose gel. ®T were genotyped by CAPS (cleaved amplified polymorphism) assay using correspondingly BseMI and EcoNI restriction sites in the intergenic region upstream PSMA6 gene. SNP C -110 ®A (PSMA6 promoter) was analysed by allele specific PCR. Information on the primer sequences, amplified and restricted fragment sizes, SNPs GenBank accession numbers, and function of the polymorphism is given in Table 1. PCR was performed in a final volume of 30 ml containing around 100 ng genomic DNA, 10× DreamTag polymerase buffer (final concentration 1×), 25 mM MgCl 2 (from 1.5 mM to 3 mM), 10 mM dNTP Mix (0.5mM), 10 pM forward and reversal primers (0.33 pM each) and 0.75 units of DreamTaq polymerase (Fermentas, Vilnius, Lithuania) . PCR denaturation at 95°C 5 min was followed by 35-40 cycles each of 30 sec of denaturation at 95°C , 30 s of annealing (at 55-63°C depending on the polymorphism analysed) and 60 s of extension at 72°C, with final extension step of 7 min at 72°C. PCR products were tested by electrophoresis in 1% agarose gel. Allele specific PCR was performed using allele specific forward primers differing only in the 3'-end polymorphic nucleotide and the reversal primer common for both alleles (Table 1) . Presence or absence of the amplified product directly indicated the presence or absence of the corresponding allele. PCR product was digested in case of CAPS assay by the corresponding restriction enzyme. Digestion was performed in final volume of 25 ml containing about 1,000 ng of DNA in PCR product, 10× Buffer R (final concentration 1×) and 0.5 units of the corresponding restriction enzyme (Fermentas, Vilnius, Lithuania) during 2 hours at 55°C or 37°C for BseMI or EcoNI, correspondingly. Results of the digestion were tested by gel electophoresis in 1% or 1.5% agarose gel. Fragment sizes of the digested amplicons are indicated in Table 1 . Primer design was performed by the Primer 3.0 programme using the 14q11.2-14q13.2 sequence information at the NCBI nucleotide service (GenBank accession NT_026437). Primers were synthesised in "Metabion International AG" (Germany).
SNP functionality was analysed in silico for the affinity to transcription factors (TF) using Genomatix software (DiAlign TF, Release 3.1, and MatInspector, Release 7.4 tools, at http://www.genomatix.de/) and scored as loss or generation of the transcription factor binding sites (TFBS) (Fig. 1) . Functionality of the coding region SNP was evaluated as amino acid substitution (Table 1) .
Data analysis. Numbers and frequencies of allele and genotype were estimated by direct gene counting. Expected heterozygocity indexes were estimated as H exp = 1-åp 2 i , where p i is the frequency of each allele at the locus. Population heterozygocity was calculated as the ratio of the number of heterozygous individuals to the total number of subjects. Deviations from the Hardy-Weinberg equilibrium were tested by the c 2 test. Significance of differences between the groups for whole loci was estimated using the c 2 test (P a < 0.05) following the additive model. In parallel, differences were also estimated for alleles and genotypes separately. Corrected significance levels (P b ) were calcu- lated by means of permutation analysis, performed using the PAST (PAlaentological Statistics, ver. 1.63) programme. Odds ratio (OR) and 95% confidence intervals were calculated using the dominant model by the MedCalc 3000 programme (http://medicalc3000.com/OddsRatio.htm).
RESULTS
Functional significance of the polymorphisms analysed is summarised in Table 1 . Four SNPs related to PSME1 and PSME2 genes were located in the corresponding exons and were nonsynonymous rare mutations. Five SNPs related to PSMA6 gene were chosen for the analysis including InDel and two SNPs in 5' upstream the gene region, and SNPs at -110 position and at -8 positions from the first ATG. The latter two are of the special interest as they were located in promoter (-1 position from the 5' UTR) and in 5'UTR close to the Kozak sequence correspondingly. In silico analysis (www.genomatix.de) revealed that the sequence encompassing SNP at -110 position possesses binding capacity to several TFs forming finally the module ETSF_SP1F_02 whose function is regulation of the gene expression by a cooperative interaction between the ubiquitously expressed factor SP1 and the lymphoid/myeloid factor PU.1. Moreover, the transition C -110
®A changes the locus affinity to two other TFs, namely to the simultaneously loss and generation of affinity to neuron-restrictive silencer factor and barbiturate-inducible element, correspondingly (Fig. 1) . All SNPs chosen for the analysis were previously identified in the European population (HapMap at http://www.hapmap.org). Recently PSMA6 gene SNPs at positions of -110 and -8 were intensively analysed for association with human disorders (Ozaki et al., 2006; Sjakste et al., 2007b , Takashima et al., 2007 Barbieri et al., 2008; Benett et al., 2008 , Freilinger et al., 2009 Lui et al., 2009 ). ®C located in 5' region upstream the PSMA6 gene) with a very low level of the rare allele presentation close to the accidental mutational rate. Loci identified as monomorphic or rare mutations were not genotyped in full JIA case/control study. Three resting loci showed higher diversity in the preliminary study and were evaluated as potentially prospective to be analysed for disease association. ®GA was revealed as the most diverse locus in both groups. However, allelic frequencies did not differ between cases and controls (frequencies of deletion and insertions were about 0.4 and 0.6 in both groups). The locus at position -8 of the PSMA6 gene was presented by common C and rare G alleles of the same frequency in case and control groups.
Genotyping results.
The locus at position -110 was found to be the most interesting. Rare allele A presentation in the control group was close to the mutational rate (frequency 0.06), but 1.7× more frequent in the case group (frequency 0.10). Differences in the A -110 allele and CG genotype frequencies were close to the statistically significant P level in JIA patients and healthy individuals (P a = 0.055, P b = 0.067, not shown), however, when an additive model was applied, the difference in C -110
®A locus was statistically significant (P a = 0.039, P b = 0.033, Table 2 ).
Genotypes. Taking into account the allele presentation, we can summarise that the loci at 2536 of PSME1, at 1153 of PSME2 and at -1910 of PSMA6 gene exist in a homozygous state in the Latvian population. All possible three genotypes were revealed only for InDel and SNP at -8 position of PSMA6 gene. Other loci were presented by the homozygotes on the common allele and heterozygotes (Table 3). The heterozygote CA locus at position -110 was found to be more frequent than it was reported in HapMap (0.12 and 0.02, correspondingly, for the Latvian population in average and HapMap, www.hapmap.org). It is of interest that the CA genotype at position -110 was more than twice more frequent in the JIA case group compared to healthy individuals (frequency 0.19 and 0.08, correspondingly) with a P value close to the statistically significant level (P a = 0.064, P b = 0.077; not shown). Application of the additive model for the locus C -110
®A genotypes revealed statistically significant differences between the groups (P a = 0.031, P b = 0.028, OR = 1.88 with 95% confidence interval ranging from 1.05 to 3.37).
DISCUSSION
We present here the results of an association study between proteasomal gene polymorphism and JIA in the Latvian population. Proteasomal genes were chosen as gene candidates, taking into account the hypothetical importance of defective proteasomal protein degradation in the pathogenesis of the disease (Deng et al., 1995; Maksymowicz and Russel, 1995; Pryhuber et al., 1996; Heward et al., 1999; Sjakste et al., 2004) . We have focussed our attention on three highly evolutionary conserved genes located in the long arm of chromosome 14 including PSME1, PSME2 and PSMA6 encoding proteasomal activator proteins PSME1 and PSME2 and the proteasomal alpha subunit PSMA6, correspondingly. Nine SNPs were genotyped, including four of PSME1 and PSME2 coding regions and five of PSMA6 non-coding region variations. High conservatism of the PSMA6 coding gene region was proved in our previous study (Sjakste et al., 2007a) . We confirmed here low genetic diversity of the proteasomal genes as coding as well noncoding gene regions. Two PSMA6 gene SNPs, including those at positions -110 and -8 from the first ATG located in gene promoter and 5'UTR, correspondingly, were of special interest because of their higher level of polymorphism and previously postulated and suggested association to several human disorders (Ozaki et al., 2006; Sjakste et al., 2007b; Takashima et al., 2007; Barbieri et al., 2008; Benett et al., 2008; Freilinger et al., 2009; Lui et al., 2009) . PSMA6 SNP at position -8 is interesting because of its suggested functionality due to location close to the Kozak sequence and possible interference with the initiation of the translation. Some diseases are caused by mutations that perturb the initiation step of translation by changing the context around the AUG start codon or introducing upstream AUG codons (Kozak, 2002; Kozak, 1997) . The context around the initiation codon of the PSMA6 gene (ACCAACaugT) does not represent classical "Kozak" consensus in the +4 position, where G is preferred (Kozak, 1997) . Occurrence of the "good" (ANNaugN) but not "perfect" (ANNaugG) context (Kozak, 2002) might increase the possible influence of mutations in the 5'-and 3'-areas from the consensus on the perturbation of the translation initiation. Using several models and approaches, Ozaki and colleagues (2006) reported that the allele G showed approximately 1.5-to 1.8-fold higher gene expression compared to the C allele and that the G allele could bind unknown nuclear factor(s) to exon 1 of PSMA6. Taken this into account, this variation was genotyped very intensively in different populations, especially in respect to the association with cardiovascular disorders (Ozaki et al., 2006; Sjakste et al., 2007b; Takashima et al., 2007; Barbieri et al., 2008; Benett et al., 2008; Freilinger et al., 2009; Lui et al., 2009 ) and DM2 (Sjakste et al., 2007b; Barbieri et al., 2008) . Results on the rare allele association with myocardial infarction (MI) are still controversial (Fig.  2) , however, statistically significant data were obtained in favour of its association with DM2 (Sjakste et al., 2007b , Barbieri et al., 2008 Fig. 2) . Data summarised in Figure 2 clearly demonstrate that, firstly, the SNP -8 allelic distribution is similar between the Latvian and other European and Asian populations and secondly, that there is no association between locus variation and JIA in the Latvian population.
The most prospective result was obtained for PSMA6 SNP at position -110. We have shown significant differences for locus C -110
®A and a borderline association between its rare allele and heterozygous genotype frequencies and JIA in the Latvian population. Previously, a borderline association between the rare A -110 allele and DM2 was revealed in the Latvian population (Sjakste et al., 2007b) . It should be stressed that in current and in previous studies (Sjakste et al., 2007b) in both Latvian and UK populations we did not reveal homozygotes for the rare allele, this is an additional indication on the negative role of this allele. In silico analysis revealed that the SNP C -110
®A transition is followed by the loss of locus affinity to TF belonging to neuron-restrictive silencer factor family and simultaneously to the generation of binding capacity to barbiturate-inducible element. Both allelic variants of the sequence encompassing SNP at -110 position possess binding capacity to several TFs that form finally the module ETSF_SP1F_02, whose function is regulation of the gene expression by a cooperative interac- tion between the ubiquitously expressed factor SP1 and the lymphoid/myeloid factor PU.1. Further progress in our knowledge of the molecular processes of the genome regulation could reveal more consequences of this variation.
The results obtained in the study are in agreement with hypothesis on the association of PSMA6 gene polymorphism and JIA and need further increased case/control study.
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